Adverse effects of chronic low level lead exposure on kidney function - a risk group study in children

被引:58
作者
Fels, LM
Wunsch, M
Baranowski, J
Norska-Borowka, I
Price, RG
Taylor, SA
Patel, S
De Broe, M
Elseviers, MM
Lauwerys, R
Roels, H
Bernard, A
Mutti, A
Gelpi, E
Rosello, J
Stolte, H
机构
[1] Hannover Med Sch, Div Nephrol, D-30625 Hannover, Germany
[2] L Warynski Silesian Med Acad, Zabrze, Poland
[3] Kings Coll London, Biochem Sect, Div Biomol Sci, London WC2R 2LS, England
[4] Univ Antwerp, Dept Nephrol Hypertens, Edegem, Belgium
[5] Univ Catholique Louvain, Unite Toxicol Ind & Med Travail, B-1200 Brussels, Belgium
[6] Univ Parma, Sch Med, Lab Ind Toxicol, I-43100 Parma, Italy
[7] CSIC, Dept Biomed Anal, Unit Mol Pathol & Biochem Inflammat, Barcelona, Spain
关键词
children; Clara cell protein; EGF; eicosanoids; glomerular and tubular function; lead exposure;
D O I
10.1093/ndt/13.9.2248
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Children have been considered a risk group for lead (Pb) toxicity, mainly because of neurophysiological or neuro-cognitive deficits following rb exposure. Blood Pb levels (b-Pb) of 100 mu g/l currently have been defined as the lowest adverse effect level. The aim of this study was to compare, with the help of urinary markers, the kidney function of children with b-Pb just above this threshold with that of unexposed children, to assess from a nephrological point of view whether the current threshold is justified and whether children really are a particularly vulnerable risk group in terms of Pb-induced kidney damage. Methods. In a cross-sectional study, 112 children, either from unexposed areas (controls, n = 50) or Pb-contaminated areas (n = 62), the latter partly with a known history of elevated b-Pb, were examined. Twenty nine urinary or serum markers mostly related to the function or integrity of specific nephron segments were determined (e.g. filtered plasma proteins, tubular enzymes, tubular antigens, eicosanoids). Results. b-Pb were 39 +/- 13 mu g/l in controls and 133 +/- 62 mu g/l in exposed children. The main findings were increased excretion rates of prostaglandins and thromboxane B-2, epidermal growth factor, beta(2)-microglobulin and Clara cell protein in the exposed children. A relationship between b-Pb and the prevalence of values above the upper reference limits was observed. Conclusions, With the help of urinary markers, nephron segment-specific effects of chronic low-level Pb exposure could be detected in children. The pattern of effects on glomerular, proximal and distal tubular and interstitial markers was similar to that previously observed in adults. The changes, however, occur at lower b-Pb levels than in adults. The current threshold appears to be justified also from a nephrological point of view, and children can indeed be considered a special risk group.
引用
收藏
页码:2248 / 2256
页数:9
相关论文
共 48 条
[1]   ASSOCIATION BETWEEN NAG-B AND CADMIUM IN URINE WITH NO EVIDENCE OF A THRESHOLD [J].
BERNARD, A ;
THIELEMANS, N ;
ROELS, H ;
LAUWERYS, R .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 52 (03) :177-180
[2]   LOW-MOLECULAR-WEIGHT PROTEINS AS MARKERS OF ORGAN TOXICITY WITH SPECIAL REFERENCE TO CLARA CELL PROTEIN [J].
BERNARD, A ;
LAUWERYS, R .
TOXICOLOGY LETTERS, 1995, 77 (1-3) :145-151
[3]   RENAL EFFECTS IN CHILDREN LIVING IN THE VICINITY OF A LEAD SMELTER [J].
BERNARD, AM ;
VYSKOCIL, A ;
ROELS, H ;
KRIZ, J ;
KODL, M ;
LAUWERYS, R .
ENVIRONMENTAL RESEARCH, 1995, 68 (02) :91-95
[4]  
BERNARD AM, 1983, CLIN CHEM, V29, P1007
[5]   SEGMENTAL SYNTHESIS AND ACTIONS OF PROSTAGLANDINS ALONG THE NEPHRON [J].
BONVALET, JP ;
PRADELLES, P ;
FARMAN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (03) :F377-F387
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   ROLE OF CYTOCHROME-P-450 EPOXYGENASE METABOLITES IN EGF SIGNALING IN RENAL PROXIMAL TUBULE [J].
BURNS, KD ;
CAPDEVILA, J ;
WEI, SZ ;
BREYER, MD ;
HOMMA, T ;
HARRIS, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 269 (04) :C831-C840
[8]  
CARDENAS A, 1993, BRIT J IND MED, V50, P17
[9]  
Centers for Disease Control, 1991, PREV LEAD POIS YOUNG
[10]  
DAVEY PG, 1982, CLIN CHEM, V28, P1330